Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma of the Oropharynx”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01156142
What this trial is testing

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Who this might be right for
Head and Neck CancerMucositisOral Complications of Radiation Therapy+1 more
Alliance for Clinical Trials in Oncology 155
Not applicableLooking for participantsNCT05451303
What this trial is testing

Detection of Oral and Throat Cancers Using OralViome Cancer Testing System

Who this might be right for
Oral Squamous Cell CarcinomaOropharynx Squamous Cell CarcinomaPremalignant Lesion
Viome 475
Testing effectiveness (Phase 2)Study completedNCT00639769
What this trial is testing

Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07428148
What this trial is testing

Lattice-Based Radiotherapy and Chemoimmunotherapy for Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma
NYU Langone Health 60
Not applicableStudy completedNCT03032250
What this trial is testing

Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer

Who this might be right for
CaregiverMalignant Head and Neck NeoplasmParanasal Sinus Squamous Cell Carcinoma+35 more
Wake Forest University Health Sciences 35
Testing effectiveness (Phase 2)Study completedNCT00006360
What this trial is testing

Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer

Who this might be right for
Head and Neck CancerRadiation Toxicity
Radiation Therapy Oncology Group
Early research (Phase 1)Study completedNCT03381183
What this trial is testing

IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma

Who this might be right for
Squamous Cell CarcinomaSquamous Cell Carcinoma of the Head and NeckMetastatic Squamous Cell Carcinoma+5 more
H. Lee Moffitt Cancer Center and Research Institute 19
Testing effectiveness (Phase 2)Study completedNCT00004070
What this trial is testing

Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 7
Not applicableStudy completedNCT02855723
What this trial is testing

Randomized, Open-label Economic and Medical Study on the Lymph Node Management of Squamous Cell Carcinoma of the Oral Cavity and Oropharynx Tumor Stage 1 or 2, Nodes 0 (T1-T2 N0) Operable

Who this might be right for
Head and Neck Tumors
University Hospital, Montpellier 307
Not applicableUnknownNCT00983697
What this trial is testing

FDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N Cancer

Who this might be right for
Head and Neck Cancer
American College of Radiology Imaging Network 292
Large-scale testing (Phase 3)Active Not RecruitingNCT06525220
What this trial is testing

Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Merus B.V. 699
Early research (Phase 1)Looking for participantsNCT07156227
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell Carcinoma+27 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00003627
What this trial is testing

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx

Who this might be right for
Head and Neck Cancer
UNICANCER 160
Testing effectiveness (Phase 2)Ended earlyNCT00017173
What this trial is testing

S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT05966194
What this trial is testing

RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer

Who this might be right for
Oral Mucositis
EpicentRx, Inc. 216
Testing effectiveness (Phase 2)Study completedNCT00095927
What this trial is testing

Randomized Amifostine For SCCHN

Who this might be right for
Chemotherapeutic Agent ToxicityHead and Neck CancerMucositis+2 more
Dana-Farber Cancer Institute 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT04858269
What this trial is testing

First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients

Who this might be right for
Head Neck CancerMetastatic Squamous Cell CarcinomaOral Cavity Squamous Cell Carcinoma+3 more
Wake Forest University Health Sciences 31
Testing effectiveness (Phase 2)Study completedNCT00389727
What this trial is testing

Simultaneous Integrated Boost (SIB)- IMRT

Who this might be right for
Carcinoma, Squamous Cell
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04609280
What this trial is testing

Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110)

Who this might be right for
Head and Neck CancerOropharynx CancerOropharyngeal Squamous Cell Carcinoma
University of Maryland, Baltimore 52
Large-scale testing (Phase 3)Study completedNCT01439724
What this trial is testing

Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients

Who this might be right for
Squamous Cell Carcinoma of NasopharynxSquamous Cell Carcinoma of OropharynxSquamous Cell Carcinoma of Hypopharynx
Instituto Nacional de Cancer, Brazil 94
Next Page
39